Novo Nordisk gives foodmakers $900 million reason to worry
Sales would have been higher if not for a shortfall following surging demand.
Source: fortune.com
Stay updated with breaking news from David Seigerman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sales would have been higher if not for a shortfall following surging demand.
Eisai Co. and partner Biogen Inc. said their drug slowed Alzheimer’s disease, making it the first medicine to blunt progression of dementia.